Author: News Desk (News Desk)

Home News Desk
Post

A. Aubrey Bodine’s Legacy: Capturing the Essence of Mid-20th Century Maryland

The photograph ‘Mending Fishing Nets (1955)’ by A. Aubrey Bodine offers a glimpse into the commercial bay industries of mid-20th century Maryland, showcasing three men repairing a gill net at Betterton. This image, part of Bodine’s extensive portfolio, underscores his reputation as one of the finest pictorialists of the twentieth century, with his work exhibited...

Post

AIRO Group Advances Middle-Mile Cargo Drone Development in Quebec’s YMX Innovation Zone

AIRO Group, a leader in aerospace and defense technologies, has announced the development of a new middle-mile, medium-lift cargo drone, alongside its expansion into the YMX Innovation Zone in Mirabel, Quebec. This initiative, led by its Electric Air Mobility segment, Jaunt Air Mobility, aims to revolutionize freight transport by offering a low-emission alternative to traditional...

Post

Asylon Robotics Secures $24 Million in Series B Funding to Revolutionize Security with Robotics and AI

Asylon, Inc., a pioneer in robotic perimeter security technology, has successfully closed a $24 million Series B funding round. This investment, spearheaded by Insight Partners and supported by Veteran Ventures Capital, Allegion Ventures, and the GO PA Fund, is set to propel Asylon into its next growth phase. The funding will accelerate product innovation, scale...

Post

Asylon Robotics Secures $24 Million in Series B Funding to Revolutionize Security with Robotics and AI

Asylon Robotics, a pioneer in robotic perimeter security technology, has successfully closed a $24 million Series B funding round. This investment was led by Insight Partners, with contributions from Veteran Ventures Capital, Allegion Ventures, and the GO PA Fund. The funding is set to propel Asylon into its next growth phase, focusing on product innovation,...

Post

Green Monke’s Hemp-Infused Happy Sodas Lead Non-Alcoholic Beverage Sales at Pabst Theater Group Venues

Green Monke, an award-winning hemp-D9 beverage brand, has reported significant success with its Happy Sodas at the Pabst Theatre Group (PTG) venues in Milwaukee, Wisconsin. Over the first six months of their partnership, Green Monke’s products have dominated non-alcoholic beverage sales, accounting for 69% of sales at larger venues and between 52-62% at mid-sized and...

Post

BitFrontier Capital Holdings, Inc. Announces Strategic Turnaround Under New CEO Dr. Jordan P. Balencic

BitFrontier Capital Holdings, Inc. (OTC: BFCH), a company previously focused on cryptocurrency mining and hosting services, has announced a significant shift in its business strategy with the appointment of Dr. Jordan P. Balencic as its new Chief Executive Officer. Dr. Balencic, a physician entrepreneur with extensive experience in the health and wellness industry, is set...

Post

Hero Response Expands Its Restoration Services to Ontario with Two New Locations

Hero Response, a nationally recognized full-service restoration leader, has announced the expansion of its operations to include two new locations in Ontario. This move underscores the company’s dedication to providing industry-leading restoration services across Canada. With over 17 years of experience, Hero Response has evolved from a plumbing-based operation into a high-tech property and commercial...

Post

ABVC BioPharma and OncoX BioPharma Strengthen Oncology Collaboration with $100,000 Milestone Payment

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, has announced the receipt of a $100,000 milestone payment from OncoX BioPharma, Inc., marking a significant step in their strategic licensing agreement initiated in 2024. This payment brings the total licensing revenue for ABVC and its subsidiaries to $1.046 million, highlighting the commercial viability and potential of their...

Post

GeoVax Revises Gedeptin® Clinical Strategy Following KEYNOTE-689 Trial Results

GeoVax Labs, Inc. has announced a significant update to its Gedeptin® clinical development program, shifting focus towards evaluating Gedeptin as a neoadjuvant therapy in combination with pembrolizumab for patients with primary, resectable head and neck squamous cell carcinoma (HNSCC). This strategic revision is a direct response to the promising results of the KEYNOTE-689 Phase 3...